<SEC-DOCUMENT>0001387131-21-007427-index.html : 20210719
<SEC-HEADER>0001387131-21-007427.hdr.sgml : 20210719
<ACCEPTANCE-DATETIME>20210719092513
ACCESSION NUMBER:		0001387131-21-007427
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210719
DATE AS OF CHANGE:		20210719
GROUP MEMBERS:		ALTIUM GROWTH FUND, LP
GROUP MEMBERS:		ALTIUM GROWTH GP, LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inmune Bio, Inc.
		CENTRAL INDEX KEY:			0001711754
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475205835
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90859
		FILM NUMBER:		211097012

	BUSINESS ADDRESS:	
		STREET 1:		1200 PROSPECT STREET
		STREET 2:		SUITE 525
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		8589643720

	MAIL ADDRESS:	
		STREET 1:		1200 PROSPECT STREET
		STREET 2:		SUITE 525
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Altium Capital Management LP
		CENTRAL INDEX KEY:			0001746382
		IRS NUMBER:				822066653
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		152 W 57 ST FL20
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2124842711

	MAIL ADDRESS:	
		STREET 1:		152 W 57 ST FL20
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>inmb-sc13g_071421.htm
<DESCRIPTION>SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
<TEXT>
Document 1 - file: inmb-sc13g_071421.htm

</DOCUMENT>
</SEC-DOCUMENT>